Dermapharm Holding SE
XETRA:DMP
Dermapharm Holding SE
Revenue
Dermapharm Holding SE
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dermapharm Holding SE
XETRA:DMP
|
Revenue
€1.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Revenue
$314k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bayer AG
XETRA:BAYN
|
Revenue
€47.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
Merck KGaA
XETRA:MRK
|
Revenue
€21B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
MPH Health Care AG
XETRA:93M1
|
Revenue
€37.4k
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Revenue
€85.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
See Also
What is Dermapharm Holding SE's Revenue?
Revenue
1.1B
EUR
Based on the financial report for Dec 31, 2023, Dermapharm Holding SE's Revenue amounts to 1.1B EUR.
What is Dermapharm Holding SE's Revenue growth rate?
Revenue CAGR 5Y
15%
Over the last year, the Revenue growth was 11%. The average annual Revenue growth rates for Dermapharm Holding SE have been 13% over the past three years , 15% over the past five years .